Japan Tissue Engineering Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Japan Tissue Engineering Co., Ltd. made a loss over the last year. Japan Tissue Engineering Co., Ltd. owes ¥0.10 for every ¥1 it owns. Japan Tissue Engineering Co., Ltd. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossJapan Tissue Engineering Co., Ltd. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
5.91The share price is 5.91 times Japan Tissue Engineering Co., Ltd.'s book value per share, higher than 92% of Healthcare companies in Japan.
Market cap
¥30.1 BThe total market value of all of Japan Tissue Engineering Co., Ltd.'s shares at today's price (share price × number of shares), larger than 57% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥5.1 BWhat Japan Tissue Engineering Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥125.35Net worth divided by the number of shares. The share price of ¥741.00 is 5.9 times this, which is the P/B above.
Return on equity (ROE)
-8.2%Japan Tissue Engineering Co., Ltd. lost 8.2% of its shareholders' money over the last year, lower than 77% of Healthcare companies in Japan.
Owes vs Owns
0.10×Japan Tissue Engineering Co., Ltd. owes ¥0.10 for every ¥1 it owns (low), lower than 91% of Healthcare companies in Japan.
Dividend yield
NoneJapan Tissue Engineering Co., Ltd. does not currently pay a dividend.
Revenue growth
-11%Revenue fell 11% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Profit growth
LossJapan Tissue Engineering Co., Ltd. made a loss in each of the last two years.
Profit margin
-33.7%Japan Tissue Engineering Co., Ltd. lost ¥34 for every ¥100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Japan Tissue Engineering Co., Ltd.: ¥30.1 B ÷ ¥5.1 B (31 Mar 2026) = 5.9.
What is Japan Tissue Engineering Co., Ltd.'s return on equity?
Japan Tissue Engineering Co., Ltd. lost 8.2% of its shareholders' money over the last year, lower than 77% of Healthcare companies in Japan.
How much does Japan Tissue Engineering Co., Ltd. owe compared with what it owns?
Japan Tissue Engineering Co., Ltd. owes ¥0.10 for every ¥1 it owns (low), lower than 91% of Healthcare companies in Japan.
Does Japan Tissue Engineering Co., Ltd. pay a dividend?
No. Japan Tissue Engineering Co., Ltd. does not currently pay a dividend.
Is Japan Tissue Engineering Co., Ltd.'s revenue growing?
Revenue fell 11% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.